407 related articles for article (PubMed ID: 31874075)
1. Attenuated
Liu Q; Li P; Luo H; Curtiss R; Kong Q
Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
[No Abstract] [Full Text] [Related]
2. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
3. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
[TBL] [Abstract][Full Text] [Related]
4. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
Wahid R; Zafar SJ; McArthur MA; Pasetti MF; Levine MM; Sztein MB
Clin Vaccine Immunol; 2014 Mar; 21(3):427-34. PubMed ID: 24429069
[TBL] [Abstract][Full Text] [Related]
5. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a.
Liu Q; Su H; Bian X; Wang S; Kong Q
Int J Med Microbiol; 2020 Jul; 310(5):151427. PubMed ID: 32654768
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.
Ali A; An SJ; Cui C; Haque A; Carbis R
Hum Vaccin Immunother; 2014; 10(6):1494-8. PubMed ID: 24603090
[TBL] [Abstract][Full Text] [Related]
8. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
10. Status of paratyphoid fever vaccine research and development.
Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
Pakkanen SH; Kantele JM; Kantele A
Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
[TBL] [Abstract][Full Text] [Related]
12. Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis.
Li P; Zhang K; Lei T; Zhou Z; Luo H
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010866. PubMed ID: 36228043
[TBL] [Abstract][Full Text] [Related]
13. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
14. Improving Our Understanding of
Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
[TBL] [Abstract][Full Text] [Related]
15. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.
Roland KL; Tinge SA; Kochi SK; Thomas LJ; Killeen KP
Vaccine; 2010 May; 28(21):3679-87. PubMed ID: 20338215
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
17. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
[TBL] [Abstract][Full Text] [Related]
18. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
[TBL] [Abstract][Full Text] [Related]
19. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
20. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
